Short Decsription
The ELISpot kit is a highly sensitive, microplate-based method for detecting cytokine secreting cells. The kit is designed for simultaneous detection and enumeration of IFN-gamma/IL-10. The complete ELISpot kit is ready to run, no test development or improvement is required.
Description
Pipette the appropriately stimulated cells directly into the microplate supported by pvdf. The PVDF membrane has been pre-coated with capture antibody against IFN-gamma/IL-10, and then the microplate is placed in a humidified CO2 incubator at 37°C for the required time. During this incubation period, the immobilized capture antibody near the secreting cell binds to the secreted IFN-gamma/IL-10.
At the desired time point, an analyte is detected using a biotinylated detection antibody and alkaline phosphatase (AP) bound to streptavidin. Horseradish peroxidase (HRP)-conjugated detection antibody is used to detect the second analyte. After incubating with BCIP/NBT (AP substrate, blue-black precipitate) and AEC (HRP substrate, red precipitate), spots formed, indicating the presence of IFN-gamma/IL-10 secreting cells. Each dot represents a single secreting cell. Spots can be counted using the ELISpot reading system or using a stereo microscope.
Features
1.Detect and quantitate individual cells secreting IFN-gamma/IL-10.
2.High sensitivity - ELISpot assays can measure responses with frequencies well below 1 in 100,000 cells.
3.No in vitro expansion of cells required.
4.High-throughput - ELISpot assays use only a small number of primary cells.
Applications
ELISpot
Molecular Mechanism of Action
A monoclonal antibody against human IFN-γ and a monoclonal antibody against human IL-10 are pre-coated on polyvinylidene fluoride (PVDF) supported microplates. Pipette appropriately stimulated cells into the wells, and place the microplate in a humidified CO2 incubator at 37°C for a period of time. During this incubation period, immobilized antibodies near the secreting cells bind to secreted IFN-γ and IL-10. After washing away all cells and unbound substances, biotinylated monoclonal antibody against human IL-10 and horseradish peroxidase-conjugated polyclonal antibody against human IFN-γ were added. After washing to remove any unbound antibody, alkaline phosphatase bound to streptavidin is added. Then the unbound enzyme is removed by washing, and the substrate solution (BCIP/NBT) is added. After flushing the BCIP/NBT in the well with deionized water, add the AEC developer solution to the well. At the location where the cytokine was located, blue-black precipitates formed and appeared in the form of spots, each spot representing an IL-10 secreting cell. A red precipitate will also form and appear in the form of spots, each of which represents a single IFN-γ secreting cell. Spots can be counted using the ELISpot reading system or using a stereo microscope.
Target
IFN-gamma/IL-10
Reactivity
Human
Detection Method
Sandwich
Method Type
Quantitative Sandwich ELISA
Sample Type
Whole Cells

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2024 Creative Biolabs. All Rights Reserved.